SCHEMBL15733262

SCHEMBL15733262

COc1nc(Cl)nc(OC)c1C(=O)NCc1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
KCNQ3 O43525 1/20 0.51
KCNQ2 O43526 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
LMNA P02545 3/20 0.50
MAPT P10636 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C19 P33261 2/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
HTT P42858 1/20 0.50
ALDH1A1 P00352 1/20 0.50
TSHR P16473 1/20 0.50
TP53 P04637 1/20 0.49
MDM2 Q00987 1/20 0.49
HPGD P15428 1/20 0.49
THRB P10828 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15733267 0.80 TSHR (0.48) MEN1KMT2AKCNQ3KCNQ2LMNA
SCHEMBL31740895 0.77 ALDH1A1 (0.58) MEN1KMT2AMAPTHTTALDH1A1
SCHEMBL6199779 0.75 MEN1 (0.45) MEN1KMT2AKCNQ3KCNQ2MAPT
SCHEMBL16562244 0.72 RAB9A (0.74) MEN1KMT2ASMN1; SMN2MAPTCYP1A2
SCHEMBL2128569 0.72 KMT2A (1.00) MEN1KMT2ASMN1; SMN2LMNACYP1A2
SCHEMBL9505080 0.71 ALDH2 (0.59) MEN1KMT2ASMN1; SMN2MAPTCYP1A2
SCHEMBL16333801 0.71 KDM4E (0.49) MEN1KMT2ASMN1; SMN2LMNAMAPT
SCHEMBL11297673 0.71 KDM4E (0.52) MEN1KMT2ASMN1; SMN2LMNAMAPT
SCHEMBL2839345 0.71 MEN1 (0.68) MEN1KMT2ASMN1; SMN2LMNAMAPT
SCHEMBL23657593 0.70 LMNA (0.72) LMNAALDH1A1TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2925316-A1 SUBSTITUTED AMINO-ARYLCARBOXAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2015-10-07 EP disclosed
WO-2014082739-A1 SUBSTITUTED AMINO-ARYLCARBOXAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2014-06-05 WO disclosed
US-20140148454-A1 SUBSTITUTED AMINO-ACRYLCARBOXAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2014-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140148454-A1 SUBSTITUTED AMINO-ACRYLCARBOXAMIDES AS KCNQ2/3 MODULATORS KCNJ2, KCNQ1, KCNQ2 MEN1 4240/4885KMT2A 260/4885KCNQ3 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.